Navigation Links
TomoTherapy sees sustained market advantage

Madison, Wis. - Fred Robertson doesn't pretend to be a fortune teller, but he believes his company, TomoTherapy, will be setting the standard in radiation therapy for some time to come.

Robertson, chief executive officer of TomoTherapy, exudes confidence that the Hi-Art System, the company's radiation therapy platform, will continue to be a ......

Full article >>> ully shaping a radiation beam with IMRT or intensity modulated radiotherapy is only a piece of the puzzle. It is just as important to know where you are delivering that beam as it is to be able to shape the beam to conform to the tumor.

The progression

That hardware platform establishes a CT scanning base that should enable a host of additional software applications. Today......

Full article >>> ibilities.

The markets that are most appealing also happen to be in two of the world's fastest-growing economies - India and China. According to Robertson, the radiation oncology market is in varying stages of maturity, and one of the key metrics is the number of linear accelerators, devices widely used in radiotherapy, per million people. That number is 13 in the United States, but it's ......

Full article >>> out worrying about the pressures of Wall Street."

......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 12/11/06


Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. TomoTherapy opens technical training center
3. TomoTherapy raises $223 million in IPO
4. TomoTherapy revises IPO money target
5. Hospital named for Madame Curie installs TomoTherapy system
6. TomoTherapy files registration statement for IPO
7. TomoTherapy to sell medical devices in India
8. TomoTherapys 100th radiology system reaches public sector
9. TomoTherapy extends reach to Germany
10. Cash-rich TomoTherapy has no plans for IPO
11. City of Hope adds second TomoTherapy system
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2017)... ... October 11, 2017 , ... ... its endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression ... guides is transformative for performing systematic gain-of-function studies. , This complement to ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that ... Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... innovation and business process optimization firm for the life sciences and healthcare industries, ... conference in San Francisco. , The presentation, “Automating GxP Validation for Agile ...
Breaking Biology Technology:
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... , March 30, 2017 The research ... system for three-dimensional (3D) fingerprint identification by adopting ground breaking 3D ... a new realm of speed and accuracy for use in identification, ... an affordable cost. ... ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
Breaking Biology News(10 mins):